Mark Coleman
Director · 7 filings · Latest: Jun 8, 2026
Axsome Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AXSM | Mark Coleman | Director | Jun 10, 2026 | Sale | $249.00 | 643 | $160.1K | 30,389 | |
AXSM | Mark Coleman | Director | Jun 8, 2026 | Option Exercise | — | 1,429 | — | 31,032 | |
AXSM | Coleman Mark | — | Jun 10, 2026 | Proposed Sale | $249.00 | 643 | $160.1K | — | |
AXSM | Mark Coleman | Director | Jun 2, 2026 | Sale | $223.39 | 5,537 | $1.2M | 29,603 | |
AXSM | Mark Coleman | Director | Jun 1, 2026 | Sale | $230.30 | 6,000 | $1.4M | 35,140 | |
AXSM | Mark Coleman | Director | May 29, 2026 | Sale | $233.46 | 6,000 | $1.4M | 41,140 | |
AXSM | Coleman Mark | — | Jun 2, 2026 | Proposed Sale | $223.39 | 5,537 | $1.2M | — | |
AXSM | Coleman Mark | — | Jun 1, 2026 | Proposed Sale | $230.30 | 6,000 | $1.4M | — | |
AXSM | Coleman Mark | — | May 29, 2026 | Proposed Sale | $233.46 | 6,000 | $1.4M | — | |
AXSM | Mark Coleman | Director | Feb 26, 2026 | Sale | $161.11 | 25,000 | $4.0M | 47,140 | |
AXSM | Coleman Mark | — | Feb 26, 2026 | Proposed Sale | $161.11 | 25,000 | $4.0M | — | |
AXSM | Mark Coleman | Director | Feb 23, 2026 | Option Exercise | $4.95 | 6,250 | $30.9K | 72,140 | |
AXSM | Mark Coleman | Director | Feb 20, 2026 | Option Exercise | $4.95 | 12,485 | $61.8K | 65,890 | |
AXSM | Mark Coleman | Director | Feb 10, 2026 | Option Exercise | $8.02 | 5,193 | $41.6K | 53,405 | |
AXSM | Coleman Mark | — | May 28, 2025 | Proposed Sale | $103.43 | 3,750 | $387.9K | — | |
AXSM | Coleman Mark | — | May 27, 2025 | Proposed Sale | $105.47 | 3,750 | $395.5K | — | |
AXSM | Coleman Mark | — | May 20, 2025 | Proposed Sale | $107.49 | 3,000 | $322.5K | — |